Nanovex Biotechnologies is a biotechnological company based in Asturias, Spain. In Nanovex we are experts in nano delivery systems for pharmaceutical or dermocosmetic applications. These nanosystems are capable of protecting, transporting and specifically delivering the active ingredients to a precise therapeutic target, thereby increasing the efficiency of the treatment whilst simultaneously reducing their secondary effects. Nanovex biotechnologies is a spin-off of University of Oviedo founded by Rebeca Alonso and Daniel Pando with the support of multiple professors in Chemistry as well as Química del Nalón in November 2014. From Nanovex, we analyze each delivery problem and customer goals to offer a tailor-made solution that ensures the success of their therapy/diagnostic method. We design an intelligent and non-toxic capsule that takes your pharmaceutical exactly where, when, and how you need it to effectively work. Nanodelivery systems: -Liposomes -Polymeric nanoparticles -Synthetic exosomes -Metallic nanoparticles Delivery strategies: -Targeted delivery -Imaging -Controlled release -Coatings